First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers

Severe attenuation and favorable immune responses following administration of a first generation Pf p52−/p36− GAP suggests that further development of live-attenuated strains using genetic engineering should be pursued.